JERILYN WRIGHT: Open Payments
NPI 1437802717 · LEXINGTON, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$455 in 26 payments from 9 companies in 2025. Trend: 2023 $152 · 2024 $329 · 2025 $455
Food & beverage: $455
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 9 | $162 |
| Otsuka America Pharmaceutical, Inc. | 6 | $90 |
| AstraZeneca Pharmaceuticals LP | 4 | $66 |
| Lilly USA, LLC | 2 | $33 |
| Lundbeck LLC | 1 | $26 |
| PFIZER INC. | 1 | $23 |
| Astellas Pharma US Inc | 1 | $21 |
| Sumitomo Pharma America, Inc. | 1 | $17 |
| GlaxoSmithKline, LLC. | 1 | $17 |
Products named: VRAYLAR, REXULTI, MOUNJARO, AIRSUPRA, UBRELVY, NURTEC ODT, Veozah, BREZTRI.
Industry payments across VA — which companies pay providers there.
